Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

S. Corbacioglu; S. Cesaro; M. Faraci; D. Valteau-Couanet; B. Gruhn; A. Rovelli; J.J. Boelens; A. Hewitt; J. Schrum; A.S. Schulz; I. Muller; J. Stein; R. Wynn; J. Greil; K. Sykora; S. Matthes-Martin; M. Fuhrer; A. O'meara; J. Toporski; P. Sedlacek; P.G. Schlegel; K. Ehlert; A. Fasth; J. Winiarski; J. Arvidson; C. Mauz-Korholz; H. Ozsahin; A. Schrauder; P. Bader; J. Massaro; R.B. D' Agostino; M. Hoyle; M. lacobelli; K.M. Debatin; C. Peters; G. dini

doi:10.1016/S0140-6736(11)61938-7

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

Translated title of the contribution: Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

S. Corbacioglu, S. Cesaro, M. Faraci, D. Valteau-Couanet, B. Gruhn, A. Rovelli, J.J. Boelens, A. Hewitt, J. Schrum, A.S. Schulz, I. Muller, J. Stein, R. Wynn, J. Greil, K. Sykora, S. Matthes-Martin, M. Fuhrer, A. O'meara, J. Toporski, P. SedlacekP.G. Schlegel, K. Ehlert, A. Fasth, J. Winiarski, J. Arvidson, C. Mauz-Korholz, H. Ozsahin, A. Schrauder, P. Bader, J. Massaro, R.B. D' Agostino, M. Hoyle, M. lacobelli, K.M. Debatin, C. Peters, G. dini

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
Original language	Undefined/Unknown
Pages (from-to)	1301-1309
Number of pages	9
Journal	LANCET ONCOLOGY
Volume	379
Issue number	9823
DOIs	https://doi.org/10.1016/S0140-6736(11)61938-7
Publication status	Published - 2012

Access to Document

10.1016/S0140-6736(11)61938-7

Cite this

Corbacioglu, S., Cesaro, S., Faraci, M., Valteau-Couanet, D., Gruhn, B., Rovelli, A., Boelens, J. J., Hewitt, A., Schrum, J., Schulz, A. S., Muller, I., Stein, J., Wynn, R., Greil, J., Sykora, K., Matthes-Martin, S., Fuhrer, M., O'meara, A., Toporski, J., ... dini, G. (2012). Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. LANCET ONCOLOGY, 379(9823), 1301-1309. https://doi.org/10.1016/S0140-6736(11)61938-7

@article{2e62e9b08fd94c16bd72bf92f56bba2f,

title = "Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.",

author = "S. Corbacioglu and S. Cesaro and M. Faraci and D. Valteau-Couanet and B. Gruhn and A. Rovelli and J.J. Boelens and A. Hewitt and J. Schrum and A.S. Schulz and I. Muller and J. Stein and R. Wynn and J. Greil and K. Sykora and S. Matthes-Martin and M. Fuhrer and A. O'meara and J. Toporski and P. Sedlacek and P.G. Schlegel and K. Ehlert and A. Fasth and J. Winiarski and J. Arvidson and C. Mauz-Korholz and H. Ozsahin and A. Schrauder and P. Bader and J. Massaro and {D' Agostino}, R.B. and M. Hoyle and M. lacobelli and K.M. Debatin and C. Peters and G. dini",

year = "2012",

doi = "10.1016/S0140-6736(11)61938-7",

language = "Undefined/Unknown",

volume = "379",

pages = "1301--1309",

journal = "LANCET ONCOLOGY",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "9823",

}

Corbacioglu, S, Cesaro, S, Faraci, M, Valteau-Couanet, D, Gruhn, B, Rovelli, A, Boelens, JJ, Hewitt, A, Schrum, J, Schulz, AS, Muller, I, Stein, J, Wynn, R, Greil, J, Sykora, K, Matthes-Martin, S, Fuhrer, M, O'meara, A, Toporski, J, Sedlacek, P, Schlegel, PG, Ehlert, K, Fasth, A, Winiarski, J, Arvidson, J, Mauz-Korholz, C, Ozsahin, H, Schrauder, A, Bader, P, Massaro, J, D' Agostino, RB, Hoyle, M, lacobelli, M, Debatin, KM, Peters, C & dini, G 2012, 'Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.', LANCET ONCOLOGY, vol. 379, no. 9823, pp. 1301-1309. https://doi.org/10.1016/S0140-6736(11)61938-7

TY - JOUR

T1 - Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

AU - Corbacioglu, S.

AU - Cesaro, S.

AU - Faraci, M.

AU - Valteau-Couanet, D.

AU - Gruhn, B.

AU - Rovelli, A.

AU - Boelens, J.J.

AU - Hewitt, A.

AU - Schrum, J.

AU - Schulz, A.S.

AU - Muller, I.

AU - Stein, J.

AU - Wynn, R.

AU - Greil, J.

AU - Sykora, K.

AU - Matthes-Martin, S.

AU - Fuhrer, M.

AU - O'meara, A.

AU - Toporski, J.

AU - Sedlacek, P.

AU - Schlegel, P.G.

AU - Ehlert, K.

AU - Fasth, A.

AU - Winiarski, J.

AU - Arvidson, J.

AU - Mauz-Korholz, C.

AU - Ozsahin, H.

AU - Schrauder, A.

AU - Bader, P.

AU - Massaro, J.

AU - D' Agostino, R.B.

AU - Hoyle, M.

AU - lacobelli, M.

AU - Debatin, K.M.

AU - Peters, C.

AU - dini, G.

PY - 2012

Y1 - 2012

U2 - 10.1016/S0140-6736(11)61938-7

DO - 10.1016/S0140-6736(11)61938-7

M3 - Article

SN - 1470-2045

VL - 379

SP - 1301

EP - 1309

JO - LANCET ONCOLOGY

JF - LANCET ONCOLOGY

IS - 9823

ER -